DANIMER Financial Statements From 2010 to 2025
| 6CU Stock | EUR 8.50 0.00 0.00% |
Check DANIMER SCIENTIFIC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DANIMER SCIENTIFIC's main balance sheet or income statement drivers, such as , as well as many indicators such as . DANIMER financial statements analysis is a perfect complement when working with DANIMER SCIENTIFIC Valuation or Volatility modules.
DANIMER |
DANIMER SCIENTIFIC Company Total Debt Analysis
DANIMER SCIENTIFIC's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current DANIMER SCIENTIFIC Total Debt | 70.41 M |
Most of DANIMER SCIENTIFIC's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DANIMER SCIENTIFIC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, DANIMER SCIENTIFIC has a Total Debt of 70.41 M. This is 97.44% lower than that of the Healthcare sector and 78.32% lower than that of the Biotechnology industry. The total debt for all Germany stocks is 98.68% higher than that of the company.
DANIMER SCIENTIFIC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DANIMER SCIENTIFIC's current stock value. Our valuation model uses many indicators to compare DANIMER SCIENTIFIC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DANIMER SCIENTIFIC competition to find correlations between indicators driving DANIMER SCIENTIFIC's intrinsic value. More Info.DANIMER SCIENTIFIC is number one stock in ebitda category among its peers. It also is number one stock in net income category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DANIMER SCIENTIFIC's earnings, one of the primary drivers of an investment's value.About DANIMER SCIENTIFIC Financial Statements
DANIMER SCIENTIFIC stakeholders use historical fundamental indicators, such as DANIMER SCIENTIFIC's revenue or net income, to determine how well the company is positioned to perform in the future. Although DANIMER SCIENTIFIC investors may analyze each financial statement separately, they are all interrelated. For example, changes in DANIMER SCIENTIFIC's assets and liabilities are reflected in the revenues and expenses on DANIMER SCIENTIFIC's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in DANIMER SCIENTIFIC. Please read more on our technical analysis and fundamental analysis pages.
Corium International, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of specialty pharmaceutical products in transdermal and transmucosal delivery systems. The company was incorporated in 1995 and is headquartered in Menlo Park, California. Corium International operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 213 people.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in DANIMER Stock
DANIMER SCIENTIFIC financial ratios help investors to determine whether DANIMER Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DANIMER with respect to the benefits of owning DANIMER SCIENTIFIC security.